- Email: [email protected]
521. Construction and Characterization of a Minimal Bovine Immunodeficiency Virus Based Lentiviral Vector
" 520. Developing EIA VV ectors Suitable for Clinical EIAV Vectors Applications Carlos E. Ibanez,1 Holger Roehl,2 Jonathan B. Rohll,3 David A. Driver,3 Diana K. Hoganson,1 Douglas J. Jolly.1,2,3 1 Product and Process Development, BioMedica Inc., San Diego, CA, United States; 2Viral Vector Biology, BioMedica Inc., San Diego, CA, United States; 3Viral Vector Systems, BioMedica, San Diego, CA, United States. D
! ′ '
" "
( 1
? 0
.(. >'.
-<) I
I855:I&I86:8/ -<2@ # >GI ! / 3
1 : "
:N,9 T& : 6
6 D T8 : % D 3
>3
0
0 G >3
3 8
521. Construction and Characterization of a Minimal Bovine Immunodeficiency V irus Based Lentiviral V ector Virus Vector Rene P. Molina,1 Meghan Matukonis,1 Robert Berkowitz,1 Mike Kaleko,1 Tianci Luo.1 1 Genetic Therapy Inc. A Novartis Company, Gaithersburg, Md, United States.
2
-2./
2. @ -@@>/ =8= > ?
2. 899 2.
2.
" D @ 1
@@> "
2. % @ %@@>
8389B
S172
522. Development of Second and Third Generation Bovine Immunodeficiency V irus Based Gene T ransfer Virus Transfer Systems Meghan K. Matukonis,1 Mengtao Li,1 Rene P. Molina,1 Mike Kaleko,1 Tianci Luo.1 1 Research, Genetic Therapy Inc., Gaithersburg, Maryland, United States. D
'
-2./
-2 G ,998/ C. 1 -
/ - / 2.
' - 3/
?
3 @ 2. .(." 3 2.
8 3 89B
-/ 3 2. -/
I -/ 2.
523. In Vivo Sustained Gene Expression Mediated by Bovine Immunodeficiency V irus Based Lentiviral V ector Virus Vector Tianci Luo,1 Kyoichi Takahashi,2 Yoshitsugu Saishin,2 Yumiko Saishin,2 Jennifer Sung,2 Sean Hackett,2 Kim Brazzell,1 Mike Kaleko,1 Peter Campochiaro.2 1 Lentiviral Vector Program, Genetic Therapy, Inc./A Novartis Company, Gaithersburg, MD, United States; 2The Department of Ophthalmology & Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, United States. ' 2 . -2./
.(."
2.
3
2.
3 ' 2.
- ?!/ E
-& 3 89 & % / ) ?! 3
-@!>/
- 3/
- 3/ @!> ?! 3 ? 3
2.
3 2.
C.
524. A REV/RRE Independent Codon Optimized Bovine Immunodeficiency Virus Based Packaging System Rene P. Molina,1 Mengtao Li,1 Meghan Matukonis,1 Mike Kaleko,1 Tianci Luo.1 1 Genetic Therapy Inc. A Novartis Company, Gaithersburg, Md, United States. @ D -@D/
E
#G
@D 0 G
2
. -2./
G
2. %! #.
1
2. Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
! ′ '
" "
( 1
? 0
.(. >'.
-<) I
I855:I&I86:8/ -<2@ # >GI ! / 3
1 : "
:N,9 T& : 6
6 D T8 : % D 3
>3
0
0 G >3
3 8
521. Construction and Characterization of a Minimal Bovine Immunodeficiency V irus Based Lentiviral V ector Virus Vector Rene P. Molina,1 Meghan Matukonis,1 Robert Berkowitz,1 Mike Kaleko,1 Tianci Luo.1 1 Genetic Therapy Inc. A Novartis Company, Gaithersburg, Md, United States.
2
-2./
2. @ -@@>/ =8= > ?
2. 899 2.
2.
" D @ 1
@@> "
2. % @ %@@>
8389B
S172
522. Development of Second and Third Generation Bovine Immunodeficiency V irus Based Gene T ransfer Virus Transfer Systems Meghan K. Matukonis,1 Mengtao Li,1 Rene P. Molina,1 Mike Kaleko,1 Tianci Luo.1 1 Research, Genetic Therapy Inc., Gaithersburg, Maryland, United States. D
'
-2./
-2 G ,998/ C. 1 -
/ - / 2.
' - 3/
?
3 @ 2. .(." 3 2.
8 3 89B
-/ 3 2. -/
I -/ 2.
523. In Vivo Sustained Gene Expression Mediated by Bovine Immunodeficiency V irus Based Lentiviral V ector Virus Vector Tianci Luo,1 Kyoichi Takahashi,2 Yoshitsugu Saishin,2 Yumiko Saishin,2 Jennifer Sung,2 Sean Hackett,2 Kim Brazzell,1 Mike Kaleko,1 Peter Campochiaro.2 1 Lentiviral Vector Program, Genetic Therapy, Inc./A Novartis Company, Gaithersburg, MD, United States; 2The Department of Ophthalmology & Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, United States. ' 2 . -2./
.(."
2.
3
2.
3 ' 2.
- ?!/ E
-& 3 89 & % / ) ?! 3
-@!>/
- 3/
- 3/ @!> ?! 3 ? 3
2.
3 2.
C.
524. A REV/RRE Independent Codon Optimized Bovine Immunodeficiency Virus Based Packaging System Rene P. Molina,1 Mengtao Li,1 Meghan Matukonis,1 Mike Kaleko,1 Tianci Luo.1 1 Genetic Therapy Inc. A Novartis Company, Gaithersburg, Md, United States. @ D -@D/
E
#G
@D 0 G
2
. -2./
G
2. %! #.
1
2. Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy